Literature DB >> 18687737

High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance.

Glen L Hortin1, Denis Sviridov, N Leigh Anderson.   

Abstract

BACKGROUND: Plasma contains thousands of proteins, but a small number of these proteins comprise the majority of protein molecules and mass. CONTENT: We surveyed proteomic studies to identify candidates for high-abundance polypeptide chains. We searched the literature for information on the plasma concentrations of the most abundant components in healthy adults and for the molecular mass of the mature polypeptide chains in plasma. Because proteomic studies usually dissociate proteins into polypeptide chains or detect short peptide segments of proteins, we summarized data on individual peptide chains for proteins containing multiple subunits or polypeptides. We collected data on about 150 of the most abundant polypeptides in plasma. The abundant polypeptides span approximately the top 4 logs of concentration in plasma, from 650 to 0.06 micromol/L on a molar basis or from about 50,000 to 1 mg/L mass abundance.
CONCLUSIONS: Data on the concentrations of the high-abundance peptide chains in plasma assist in understanding the composition of plasma and potential approaches for clinical laboratory or proteomic analysis of plasma proteins. Development of more extensive databases regarding the plasma concentrations of proteins in health and diseases would promote diagnostic and proteomic advances.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687737     DOI: 10.1373/clinchem.2008.108175

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  70 in total

1.  Therapeutic effects of systemic administration of chaperone αB-crystallin associated with binding proinflammatory plasma proteins.

Authors:  Jonathan B Rothbard; Michael P Kurnellas; Sara Brownell; Chris M Adams; Leon Su; Robert C Axtell; Rong Chen; C Garrison Fathman; William H Robinson; Lawrence Steinman
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

2.  Combining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysis.

Authors:  Sonja Volk; Thomas D Schreiber; David Eisen; Calvin Wiese; Hannes Planatscher; Christopher J Pynn; Dieter Stoll; Markus F Templin; Thomas O Joos; Oliver Pötz
Journal:  Mol Cell Proteomics       Date:  2012-04-23       Impact factor: 5.911

3.  MALDI immunoscreening (MiSCREEN): a method for selection of anti-peptide monoclonal antibodies for use in immunoproteomics.

Authors:  Morteza Razavi; Matthew E Pope; Martin V Soste; Brett A Eyford; Angela M Jackson; N Leigh Anderson; Terry W Pearson
Journal:  J Immunol Methods       Date:  2010-11-13       Impact factor: 2.303

4.  Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers.

Authors:  Penelope M Drake; Birgit Schilling; Richard K Niles; Akraporn Prakobphol; Bensheng Li; Kwanyoung Jung; Wonryeon Cho; Miles Braten; Halina D Inerowicz; Katherine Williams; Matthew Albertolle; Jason M Held; Demetris Iacovides; Dylan J Sorensen; Obi L Griffith; Eric Johansen; Anna M Zawadzka; Michael P Cusack; Simon Allen; Matthew Gormley; Steven C Hall; H Ewa Witkowska; Joe W Gray; Fred Regnier; Bradford W Gibson; Susan J Fisher
Journal:  J Proteome Res       Date:  2012-03-13       Impact factor: 4.466

5.  Supramolecular Polymeric Assemblies for the Selective Depletion of Abundant Acidic Proteins in Serum.

Authors:  Mahalia A C Serrano; Jingjing Gao; Katrina A Kelly; S Thayumanavan; Richard W Vachet
Journal:  ACS Appl Mater Interfaces       Date:  2018-11-15       Impact factor: 9.229

6.  The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes.

Authors:  Ernesto S Nakayasu; Wei-Jun Qian; Carmella Evans-Molina; Raghavendra G Mirmira; Decio L Eizirik; Thomas O Metz
Journal:  Expert Rev Proteomics       Date:  2019-06-24       Impact factor: 3.940

7.  Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma.

Authors:  Michael A Kuzyk; Derek Smith; Juncong Yang; Tyra J Cross; Angela M Jackson; Darryl B Hardie; N Leigh Anderson; Christoph H Borchers
Journal:  Mol Cell Proteomics       Date:  2009-05-01       Impact factor: 5.911

8.  Variation and quantification among a target set of phosphopeptides in human plasma by multiple reaction monitoring and SWATH-MS2 data-independent acquisition.

Authors:  Anna M Zawadzka; Birgit Schilling; Jason M Held; Alexandria K Sahu; Michael P Cusack; Penelope M Drake; Susan J Fisher; Bradford W Gibson
Journal:  Electrophoresis       Date:  2014-07-10       Impact factor: 3.535

Review 9.  Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics.

Authors:  Robert E Gerszten; Aarti Asnani; Steven A Carr
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

10.  Evaluating the effects of preanalytical variables on the stability of the human plasma proteome.

Authors:  Maria E Hassis; Richard K Niles; Miles N Braten; Matthew E Albertolle; H Ewa Witkowska; Carl A Hubel; Susan J Fisher; Katherine E Williams
Journal:  Anal Biochem       Date:  2015-03-10       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.